EUVIMEDEUVIMED entdecken
Vergleichsstudie

HER2 Intratumoral Heterogeneity in Salivary Duct Carcinoma: Association With Treatment Response and Comparison Between Primary and Metastatic Lesions

Yoshitaka Utsumi, Masato Nakaguro, Daisuke Kawakita, Yoshitaka Honma, Hideaki Takahashi, Satoshi Kano, Hideaki Hirai, Aoi Sukeda, Takashi Matsuki, Nami Hirakawa, Takeshi Ushigusa, Yoshiya Horimoto und 3 weitere

Modern Pathology · 2026-11 · 39 (11) · 101074

DOI: 10.1016/j.modpat.2026.101074 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Modern Pathology, 2026-11. Verfasst von Yoshitaka Utsumi und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anatomic Pathology, Tokyo Medical University, Tokyo, Japan. Hauptthemen laut MEDLINE: Erb-b2 Receptor Tyrosine Kinases, Salivary Gland Neoplasms, Salivary Ducts, Antineoplastic Combined Chemotherapy Protocols. Die Arbeit nennt 84 Literaturangaben. Gefördert von: Japan Society for the Promotion of Science.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Erb-b2 Receptor Tyrosine KinasesSalivary Gland NeoplasmsSalivary DuctsAntineoplastic Combined Chemotherapy ProtocolsBiomarkers, TumorCarcinoma, DuctalHumansFemaleMiddle AgedRetrospective StudiesAgedTrastuzumabAdultMaleDocetaxelAged, 80 and overTreatment Effect HeterogeneityImmunohistochemistryTreatment Outcome

Stichwörter der Autor:innen

HER2 amplification levelHER2 intratumoral heterogeneityHER2-targeted therapysalivary duct carcinomasalivary gland cancertrastuzumab

Substanzen

Erb-b2 Receptor Tyrosine KinasesERBB2 protein, humanTrastuzumabDocetaxelBiomarkers, Tumor

Autor:innen und Institutionen

  • Department of Anatomic Pathology, Tokyo Medical University, Tokyo, Japan.
  • Departments of Pathology and Laboratory Medicine, Nagoya University Hospital, Nagoya, Japan.
  • Department of Otorhinolaryngology, Head and Neck Surgery, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan.
  • Department of Head and Neck, Esophageal Medical Oncology, National Cancer Center Hospital, Tokyo, Japan.
  • Department of Otolaryngology - Head and Neck Surgery, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Sapporo, Japan.
  • Department of Head and Neck Surgery, Kanagawa Cancer Center, Kanagawa, Japan.

Förderung

  • Japan Society for the Promotion of Science

Zitieren

APA

Utsumi, Y., Nakaguro, M., Kawakita, D., Honma, Y., Takahashi, H., Kano, S., Hirai, H., Sukeda, A., Matsuki, T., Hirakawa, N., Ushigusa, T., Horimoto, Y., Tsuda, H., Tada, Y., & Nagao, T. (2026). HER2 Intratumoral Heterogeneity in Salivary Duct Carcinoma: Association With Treatment Response and Comparison Between Primary and Metastatic Lesions. Modern Pathology, 39(11), 101074. https://doi.org/10.1016/j.modpat.2026.101074

Vancouver

Utsumi Y, Nakaguro M, Kawakita D, Honma Y, Takahashi H, Kano S, et al. HER2 Intratumoral Heterogeneity in Salivary Duct Carcinoma: Association With Treatment Response and Comparison Between Primary and Metastatic Lesions. Modern Pathology. 2026;39(11):101074. doi:10.1016/j.modpat.2026.101074

BibTeX
@article{Utsumi2026,
  author = {Utsumi, Yoshitaka and Nakaguro, Masato and Kawakita, Daisuke and Honma, Yoshitaka and Takahashi, Hideaki and Kano, Satoshi and Hirai, Hideaki and Sukeda, Aoi and Matsuki, Takashi and Hirakawa, Nami and Ushigusa, Takeshi and Horimoto, Yoshiya and Tsuda, Hitoshi and Tada, Yuichiro and Nagao, Toshitaka},
  title = {HER2 Intratumoral Heterogeneity in Salivary Duct Carcinoma: Association With Treatment Response and Comparison Between Primary and Metastatic Lesions},
  journal = {Modern Pathology},
  year = {2026},
  volume = {39},
  number = {11},
  pages = {101074},
  doi = {10.1016/j.modpat.2026.101074}
}
Kostenlos starten →